For innovation to be successful it must be developed in collaboration with those set to use or benefit from it.
Involvement and co-production with people, public, carers, and communities is a growing and thriving agenda across the AHSN Network, and is even more important than it has ever been, given the experiences of the COVID-19 pandemic.
With this in mind, during 2020/2021 the Network reviewed activity across AHSNs to support a more strategic approach to involvement and co-production of innovation and developed its co-production strategy.
Read more about our approach to co-production and patient and public involvement.
Angie Doshani, is founder of JanamApp and Consultant Obstetrician and Gynaecologist at University Hospitals of Leicester NHS Trust. JanamApp is a ground-breaking solution addressing the disparities in pregnancy outcomes faced by South Asian women, who experience a 1.8 times higher risk compared to their white counterparts. The challenges of some women from this demographic include [...]
Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]
Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]
